je.st
news
Tag: interim
Technicote names Russ Pletcher interim president
2017-08-14 16:56:00| Label and Narrow Web Breaking News
Pletcher joined the Board in 2006 and will continue to serve on the board after a full-time president is identified.
Tags: names
president
interim
russ
C&C Group names former SABMiller finance director Jonathan Solesbury interim CFO
2017-08-01 17:05:00| Daily beverage news and comment - from just-drinks.com
C&C Group has appointed Jonathan Solesbury to the role of interim group chief financial officer.
Tags: group
director
finance
names
Telecom Italia sales up 6% in Q2, de Puyfontaine named interim CEO
2017-07-28 08:01:00| Telecompaper Headlines
(Telecompaper) The company added that on an organic basis, excluding exchange rate effects, its revenues rose 3.7 percent in the April to June period, an improvement on rises of 2.6 percent and 0.8 percent in the previous two quarters. The company's consolidated EBITDA for the quarter was up 5.5 percent on like for like terms to EUR 2.1 billion, attributed in part to the cost recovery plan launched a year earlier in Italy and in the third quarter of 2016 at its TIM Brasil unit. The group's adjusted net debt came to EUR 25.1 billion at the end of Q2, some EUR 131 million less than at the end of March.
Interim Administrative Rule Draft
2017-06-17 01:54:41| PortlandOnline
PDF Document, 825kbCategory: Smart Autonomous Vehicles Initiative (SAVI)
Tags: rule
administrative
draft
interim
Interim Results from Phase 1b/2 Study Evaluating the Combination of Mercks KEYTRUDA (pembrolizumab) and Eisais HALAVEN (eribulin mesylate) Injection in Metastatic Triple-Negative Breast Cancer Presented at 2016 SABCS
2016-12-12 13:00:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. & WOODCLIFF LAKE, N.J. KENILWORTH, N.J. & WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Eisai Inc. today announced new interim data investigating Mercks anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in combination with Eisais microtubule dynamics inhibitor, HALAVEN (eribulin), in patients with metastatic triple-negative breast cancer (TNBC). Language: English Contact: Media:MerckPamela Eisele, 267-305-3558orKim Hamilton, (908) 740-1863orEisai Inc.Laurie Landau, 201-746-2510orInvestors:MerckTeri Loxam, 908-740-1986orAmy Klug, 908-740-1898orEisai Inc.Ivor Macleod, 201-746-2660 Ticker Slug: Ticker: MRK Exchange: NYSE @Merck read more
Tags: results
study
presented
combination
Sites : [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] next »